EFFECTS OF ANTENATAL ANTIHELMINTHIC TREATMENT ON PREGNANCY OUTCOMES IN UITH ILORIN: A RANDOMISED CONTROLLED TRIAL.

Not Applicable

• Conditions: Helminthiasis; Pregnancy and Childbirth

• Registration Number: PACTR202008475715326
• Lead Sponsor: Dr Afusat Olabinjo

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-07-21
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 176

Inclusion Criteria

•All consenting pregnant women with singleton foetus presenting between 14 and 26 weeks.

Exclusion Criteria

•Non consenting pregnant women.
•Patients with known hypersensitivity to benzimidazole.
•Baseline haemoglobin concentration less than 7g/dl.
•Patients with multiple gestations.
•Patients with sickle cell disease
•Patients with chronic kidney disease.
•Retroviral disease patients.
•Patients that may require blood transfusion during the course of pregnancy.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Maternal stool parasite density

Secondary Outcome Measures

Name	Time	Method
The secondary outcomes will be determined by maternal anaemia and neonatal birth weight, APGAR scores NICU admission and still birth.